113 related articles for article (PubMed ID: 16683522)
1. [Liver targeting of cationic liposomes modified with soybean-derived sterylglucoside in vitro].
Shi J; Qi XR; Yang L; Fei R; Wei L
Yao Xue Xue Bao; 2006 Jan; 41(1):19-23. PubMed ID: 16683522
[TBL] [Abstract][Full Text] [Related]
2. Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol.
Qi XR; Yan WW; Shi J
World J Gastroenterol; 2005 Aug; 11(32):4947-52. PubMed ID: 16124043
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and biodistribution of soybean sterylglucoside and polyethylene glycol-modified cationic liposomes and their complexes with antisense oligodeoxynucleotide.
Shi J; Yan WW; Qi XR; Maitani Y; Nagai T
Drug Deliv; 2005; 12(6):349-56. PubMed ID: 16253950
[TBL] [Abstract][Full Text] [Related]
4. [Biodistribution and hepatocytes targeting of cationic liposomes surface-modified with sterylglucoside and golyethylene glycol].
Shi J; Yan WW; Qi XR; Yang L; Zhang L
Yao Xue Xue Bao; 2004 Jul; 39(7):551-5. PubMed ID: 15493849
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells.
Maitani Y; Kawano K; Yamada K; Nagai T; Takayama K
J Control Release; 2001 Aug; 75(3):381-9. PubMed ID: 11489324
[TBL] [Abstract][Full Text] [Related]
6. [Influence of soybean-derived sterylglucoside and amphipathic polyethylene glycol on the cellular delivery and anisotropy of different cationic liposomes].
Yan W; Fei R; Wang W; Qi X; Wei L; Cong X; Wang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 35(3):324-8. PubMed ID: 12914258
[TBL] [Abstract][Full Text] [Related]
7. Liver targeting liposomes containing beta-sitosterol glucoside with regard to penetration-enhancing effect on HepG2 cells.
Kawano K; Nakamura K; Hayashi K; Nagai T; Takayama K; Maitani Y
Biol Pharm Bull; 2002 Jun; 25(6):766-70. PubMed ID: 12081144
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
[TBL] [Abstract][Full Text] [Related]
9. Application of sterylglucoside-containing particles for drug delivery.
Maitani Y; Nakamura K; Kawano K
Curr Pharm Biotechnol; 2005 Feb; 6(1):81-93. PubMed ID: 15727558
[TBL] [Abstract][Full Text] [Related]
10. Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting.
Shimizu K; Maitani Y; Takayama K; Nagai T
Biol Pharm Bull; 1997 Aug; 20(8):881-6. PubMed ID: 9300135
[TBL] [Abstract][Full Text] [Related]
11. Association of liposomes containing a soybean-derived sterylglucoside mixture with rat primary cultured hepatocytes.
Shimizu K; Maitani Y; Takahashi N; Takayama K; Nagai T
Biol Pharm Bull; 1998 Aug; 21(8):818-22. PubMed ID: 9743249
[TBL] [Abstract][Full Text] [Related]
12. [Cationic lipid and polyethylene glycol enhance liposomes-mediated cell transfection and increase the fluidity of liposomes membranes].
Yan WW; Qi XR; Wei L; Fei R; Cong X; Wang Y
Yao Xue Xue Bao; 2003 Sep; 38(9):698-701. PubMed ID: 14730922
[TBL] [Abstract][Full Text] [Related]
13. Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models.
Shimizu K; Qi XR; Maitani Y; Yoshii M; Kawano K; Takayama K; Nagai T
Biol Pharm Bull; 1998 Jul; 21(7):741-6. PubMed ID: 9703260
[TBL] [Abstract][Full Text] [Related]
14. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells.
Shigeta K; Kawakami S; Higuchi Y; Okuda T; Yagi H; Yamashita F; Hashida M
J Control Release; 2007 Apr; 118(2):262-70. PubMed ID: 17267065
[TBL] [Abstract][Full Text] [Related]
15. [Transfection and anti-HBV effect mediated by the hepatocytes-targeting cationic liposomes co-modified with beta-sitosterol-beta-D-glucoside and Brij 35].
Zhang Y; Qi XR; Gao Y; Wei L
Yao Xue Xue Bao; 2006 Nov; 41(11):1111-5. PubMed ID: 17262957
[TBL] [Abstract][Full Text] [Related]
16. Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA.
Sonoke S; Ueda T; Fujiwara K; Kuwabara K; Yano J
Biol Pharm Bull; 2011; 34(8):1338-42. PubMed ID: 21804229
[TBL] [Abstract][Full Text] [Related]
17. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation.
Pathak P; Dhawan V; Magarkar A; Danne R; Govindarajan S; Ghosh S; Steiniger F; Chaudhari P; Gopal V; Bunker A; Róg T; Fahr A; Nagarsenker M
Int J Pharm; 2016 Jul; 509(1-2):149-158. PubMed ID: 27231122
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of dipalmitoylphosphatidylcholine liposomes containing a soybean-derived sterylglucoside mixture for liver targeting.
Shimizu K; Maitani Y; Takayama K; Nagai T
J Drug Target; 1996; 4(4):245-53. PubMed ID: 9010814
[TBL] [Abstract][Full Text] [Related]
19. A novel lactoferrin-modified stealth liposome for hepatoma-delivery of triiodothyronine.
Pireddu R; Pibiri M; Valenti D; Sinico C; Fadda AM; Simbula G; Lai F
Int J Pharm; 2018 Feb; 537(1-2):257-267. PubMed ID: 29294323
[TBL] [Abstract][Full Text] [Related]
20. [In vitro targeting effect of lactoferrin modified PEGylated liposomes for hepatoma cells].
Wei MY; Zou Q; Wu CB; Xu YH
Yao Xue Xue Bao; 2015 Oct; 50(10):1272-9. PubMed ID: 26837173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
